SPP1 and neoplasm: Moreover, when SPP1 influences the production of an immunosuppressive TME by CAFs, it inhibits T cell proliferation and activation, recruits regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), and reduces the effectiveness of the host’s anti-tumor immune response [62, 63].